The Big Question: Are we on the brink of a breakthrough in the fight against prostate cancer?

Why are we asking this now?

Scientists funded by Cancer Research UK have found seven new genetic variations that are linked with the development of prostate cancer and can raise a man's risk of developing the disease by up to threefold. This is the largest number of genetic risk factors to be uncovered by a single genome-wide study and represents a major advance in understanding the genetic basis of the disease. Six other genetic variations have also been linked with prostate cancer in two separate studies published simultaneously in the current issue of the journal Nature Genetics.

What does this advance mean for prostate cancer?

It means we are closer to having a genetic test for the disease that could predict who is at risk. Those identified could then be targeted for regular screening and early treatment – in theory. One test, called deCODE and marketed by an Icelandic company at £250, has already been launched that checks for the presence of eight of the gene variations but it has been dismissed by rival researchers as "premature". Cancer Research UK scientists say any genetic test raises difficult ethical and practical issues which must be addressed first, such as how men at high risk should be counselled and how often they should be tested for the presence of the disease. Their own test is not expected to be ready for three to four years.

How big a problem is prostate cancer?

Very big and getting worse. It is the commonest male cancer, with 35,000 new cases and 10,000 deaths a year. As a killer of men it is second only to lung cancer and not far short of breast cancer, which kills around 12,500 women a year but gets far more attention and at least 10 times more research funding. Its incidence is rising rapidly, partly because doctors have begun to look for it and are finding cancer that in the past would have gone undiagnosed. It runs in families – if you have a relative with the disease your own risk is doubled, and if he was diagnosed before 60 it raises your risk almost four- fold. There is an urgent need for an accurate test that can tell who is going to get prostate cancer and who will die from it without treatment.

What is the prostate and what are the symptoms of prostate cancer?

It is a gland, only present in men, surrounding the urethra, the tube that carries urine from the bladder to the penis. It is the size of a walnut and produces the semen in which the sperm, made in the testicles, can swim. In one in three men in middle age, the prostate becomes enlarged, causing symptoms such as difficulty in urinating, a weak stream or increased frequency. However, in nine out of ten cases the cause of the symptoms is benign. Only in one out of ten is it cancer.

How is it detected?

With difficulty. The first thing a GP will do for a patient who complains of the above symptoms is check to see if the prostate is enlarged, which can be simply done by inserting a finger in the rectum and feeling it through the bowel wall. The next stage is a blood test for prostate specific antigen – the PSA test – which, if raised, may indicate the presence of cancer. That is followed by a biopsy, a procedure in which a hollow needle is inserted through the penis to take samples of tissue from the prostate to check for cancerous cells.

Is prostate cancer different from other cancers?

Yes, in one crucial respect – more men die with it than from it. It is curable but may not need treatment. This is because in many men it is slow growing – so slow that they can live with it without ill effects and die of something else. However, some prostate cancers are aggressive. This makes determining who is at risk complicated – even when cancer is diagnosed it is not obvious what should be done. The biggest risk factor for prostate cancer, as with other cancers, is age. Most men are diagnosed in their 70s.

How reliable is the PSA test?

Not as reliable as patients or doctors would like. A high reading indicates possible cancer and normally triggers the next stage – a biopsy. But research shows that seven out of 10 men with a high PSA test will not have cancer. Worse, two in a hundred with a low reading will have significant cancer. So a lot of men will receive treatment (a biopsy) they don't need and some will not receive treatment that they do.

Even so, isn't it worth men in middle age being screened?

Men may have good reasons for taking a PSA test – symptoms such as difficulty urinating, or a family history. But they need to ask themselves what they will do if the results are high. The biopsy is a painful, invasive procedure.

If cancer is found, it may lead to surgery, which carries risks, and/or radiotherapy and chemo-therapy which have side-effects. But the cancer may not need treating. In those cases, PSA testing and the treatment it triggers will have caused pain and anxiety and no health benefit.

Even the professor who developed the PSA test in 1987, Thomas Stamey, said in 2004 that it was "all but useless". His discovery spawned a vast prostate screening industry in the US, where more than 250,000 men are diagnosed with the cancer each year. But Prof Stamey now says the test merely indicates the size of the prostate and may do more harm than good by encouraging over-treatment.

Are better tests and treatments likely?

Yes. The latest research has identified two genes that offer scientists new targets. One, called LMKT2, codes for a signalling protein called kinase which is also altered in some other cancers and against which drugs are already being developed.

The second gene, called MSMB, codes for a protein whose level in the blood falls as prostate cancer develops, raising the possibility that it could provide a new more accurate blood test for the disease to replace the PSA test.

The most urgent need is for a means of distinguishing the "tigers" – aggressive, fast growing prostate cancers – from the "pussy cats" – slow growing cancers which need no treatment. Scientists are getting better at telling them apart and recommending treatment or "watchful waiting", in which the progress of the cancer is regularly monitored. But there is still a lot further to go.

Can prostate cancer be beaten?

Yes

* A new genetic test will enable men at high risk to be identified for regular screening

* More accurate blood tests based on a new gene target could mean earlier identification of the disease

* Treatment could be offered to those men with fast-growing, aggressive cancers

No

* The existing PSA blood test cannot distinguish between a cancerous prostate and a benignly enlarged one

* Even when cancer is diagnosed there is often no way of knowing if it needs treating

* Prostate cancer is unique in that it can be so slow to develop that more men die with it than from it

Start your day with The Independent, sign up for daily news emails
Sport
Bafetibis Gomis of Swansea City is stretchered off at White Hart Lane
football
News
Jerry Seinfeld Comedians in Cars Getting Coffee
peopleSitcom star urges men to be more supportive of women than ever
Life and Style
Living for the moment: Julianne Moore playing Alzheimer’s sufferer Alice
health
News
Jay Z
businessJay-Z's bid for Spotify rival could be blocked
Sport
footballLouis van Gaal is watching a different Manchester United and Wenger can still spring a surprise
News
The spider makes its break for freedom
VIDEO
ebooks
ebooksA special investigation by Andy McSmith
Voices
A propaganda video shows Isis forces near Tikrit
voicesAdam Walker: The Koran has violent passages, but it also has others that explicitly tells us how to interpret them
Arts and Entertainment
books
News
people
Sport
Ashley Young celebrates the winner for Manchester United against Newcastle
footballNewcastle v United player ratings
Life and Style
love + sex
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs General

Ashdown Group: Senior Accountant - ACCA, ACA or ACMA - Construction Sector

£45000 - £50000 per annum + Benefits: Ashdown Group: Senior Accountant (ACCA, ...

Recruitment Genius: Media Sales Executive - PR and Broadcast - OTE £35,000

£16000 - £35000 per annum: Recruitment Genius: This company has an exciting op...

Recruitment Genius: Customer Service Advisor - Shifts

£17000 per annum: Recruitment Genius: This European market leader for security...

Recruitment Genius: Freelance AutoCAD Technician

Negotiable: Recruitment Genius: A Freelance AutoCAD Technician is required to ...

Day In a Page

War with Isis: Iraq's government fights to win back Tikrit from militants - but then what?

Baghdad fights to win back Tikrit from Isis – but then what?

Patrick Cockburn reports from Kirkuk on a conflict which sectarianism has made intractable
Living with Alzheimer's: What is it really like to be diagnosed with early-onset dementia?

What is it like to live with Alzheimer's?

Depicting early-onset Alzheimer's, the film 'Still Alice' had a profound effect on Joy Watson, who lives with the illness. She tells Kate Hilpern how she's coped with the diagnosis
The Internet of Things: Meet the British salesman who gave real-world items a virtual life

Setting in motion the Internet of Things

British salesman Kevin Ashton gave real-world items a virtual life
Election 2015: Latest polling reveals Tories and Labour on course to win the same number of seats - with the SNP holding the balance of power

Election 2015: A dead heat between Mr Bean and Dick Dastardly!

Lord Ashcroft reveals latest polling – and which character voters associate with each leader
Audiences queue up for 'true stories told live' as cult competition The Moth goes global

Cult competition The Moth goes global

The non-profit 'slam storytelling' competition was founded in 1997 by the novelist George Dawes Green and has seen Malcolm Gladwell, Salman Rushdie and Molly Ringwald all take their turn at the mic
Pakistani women come out fighting: A hard-hitting play focuses on female Muslim boxers

Pakistani women come out fighting

Hard-hitting new play 'No Guts, No Heart, No Glory' focuses on female Muslim boxers
Leonora Carrington transcended her stolid background to become an avant garde star

Surreal deal: Leonora Carrington

The artist transcended her stolid background to become an avant garde star
LGBT History Month: Pupils discuss topics from Sappho to same-sex marriage

Education: LGBT History Month

Pupils have been discussing topics from Sappho to same-sex marriage
11 best gel eyeliners

Go bold this season: 11 best gel eyeliners

Use an ink pot eyeliner to go bold on the eyes with this season's feline flicked winged liner
Cricket World Cup 2015: Tournament runs riot to make the event more hit than miss...

Cricket World Cup runs riot to make the event more hit than miss...

The tournament has reached its halfway mark and scores of 300 and amazing catches abound. One thing never changes, though – everyone loves beating England
Katarina Johnson-Thompson: Heptathlete ready to jump at first major title

Katarina Johnson-Thompson: Ready to jump at first major title

After her 2014 was ruined by injury, 21-year-old Briton is leading pentathlete going into this week’s European Indoors. Now she intends to turn form into gold
Syrian conflict is the world's first 'climate change war', say scientists, but it won't be the last one

Climate change key in Syrian conflict

And it will trigger more war in future
How I outwitted the Gestapo

How I outwitted the Gestapo

My life as a Jew in wartime Berlin
The nation's favourite animal revealed

The nation's favourite animal revealed

Women like cuddly creatures whilst men like creepy-crawlies
Is this the way to get young people to vote?

Getting young people to vote

From #VOTESELFISH to Bite the Ballot